The Negro In The Drug Manufacturing Industry
Download The Negro In The Drug Manufacturing Industry full books in PDF, epub, and Kindle. Read online free The Negro In The Drug Manufacturing Industry ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Gordon F. Bloom |
| Publisher | : University of Pennsylvania Press |
| Total Pages | : 240 |
| Release | : 2016-11-11 |
| Genre | : Business & Economics |
| ISBN | : 1512800937 |
This book is a volume in the Penn Press Anniversary Collection. To mark its 125th anniversary in 2015, the University of Pennsylvania Press rereleased more than 1,100 titles from Penn Press's distinguished backlist from 1899-1999 that had fallen out of print. Spanning an entire century, the Anniversary Collection offers peer-reviewed scholarship in a wide range of subject areas.
| Author | : Maureen Mackintosh |
| Publisher | : Springer |
| Total Pages | : 353 |
| Release | : 2016-02-03 |
| Genre | : Political Science |
| ISBN | : 1137546476 |
This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations' needs and demands. Research for this book has been selected as one of the 20 best examples of the impact of UK research on development. See http://www.ukcds.org.uk/the-global-impact-of-uk-research for further details.
| Author | : Katherine Eban |
| Publisher | : HarperCollins |
| Total Pages | : 523 |
| Release | : 2020-06-23 |
| Genre | : Medical |
| ISBN | : 0063054108 |
A NEW YORK TIMES BESTSELLER * New York Times Notable Book * Best Book of the Year: New York Public Library, Kirkus Reviews, Science Friday With a new postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
| Author | : F. Marion Fletcher |
| Publisher | : University of Pennsylvania Press |
| Total Pages | : 148 |
| Release | : 1971 |
| Genre | : Business & Economics |
| ISBN | : |
Report on research into employment policy concerning the hiring of Blacks as pharmacists in the USA - covers historical aspects of discrimination, current levels and patterns of negro employment in drugstores and the reasons therefor, employment opportunity trends and prospects, recruitment procedures, labour demand and labour supply of negro pharmacists, etc. References and statistical tables.
| Author | : Ellen F. M. 't Hoen |
| Publisher | : |
| Total Pages | : 136 |
| Release | : 2009 |
| Genre | : Agreement on Trade-Related Aspects of Intellectual Property Rights |
| ISBN | : 9789079700066 |
In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.
| Author | : Herbert R. Northrup |
| Publisher | : University of Pennsylvania Press |
| Total Pages | : 688 |
| Release | : 2018-01-09 |
| Genre | : Business & Economics |
| ISBN | : 151282111X |
The authors examine both past and current practices and policies influencing black employment in the railroad, airline, trucking, and urban transit industries. Technological unemployment, declining traffic, and discrimination by unions, carriers, and government agencies have reduced both the number and proportion of blacks in the railroad industry, which was once one of the nation's leading employers of blacks. These, same railroading mores have affected black employment in airlines and urban transit in the past but today other forces are working to improve black representation in the former and leading to a heavily black work force in the latter. In the trucking industry, the Teamsters' Union and government policy are keys to Negro employment, with the union dragging its feet in supporting an increased number of black over-the-road drivers. A final section compares the situations in the four industries and forecasts future Negro employment trends in light of the most recent employment data, occupational needs, governmental policy, and other significant factors.
| Author | : Elaine Gale Wrong |
| Publisher | : |
| Total Pages | : 822 |
| Release | : 1973 |
| Genre | : African Americans |
| ISBN | : |
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 235 |
| Release | : 2018-03-01 |
| Genre | : Medical |
| ISBN | : 0309468086 |
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
| Author | : Armand J. Thieblot, Jr. |
| Publisher | : University of Pennsylvania Press |
| Total Pages | : 444 |
| Release | : 2016-11-15 |
| Genre | : Business & Economics |
| ISBN | : 1512820008 |
This volume investigates African-American employment in banking and insurance in the United States. The authors describe how these once almost all-white industries are now employing large numbers of African-American and what problems remain to be solved before equal employment opportunity can be fully attained. Appendices tell the story of African-American-owned banking and insurance companies and their status today. Located in primarily urban areas, banks and insurance companies may soon be among the largest employers of African-Americans. The centralized personnel structure of banks gives them a significant advantage in employing African Americans, but the authors find that both banks and insurance companies have been slow to employ black managerial personnel. This study is based upon individual reports first published in the Racial Policies of American Industry series. A final chapter compares and contrasts the situations in banking and insurance, paying particular attention to the reasons for varying progress in the two industries. Founded in 1921 as a separate Wharton department, the Industrial Research Unit has a long record of publication and research in the labor market, productivity, union relations, and business report fields. Major Industrial Research Unit studies are published as research projects are completed. This volume is Study no. 47.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 216 |
| Release | : 2000-12-30 |
| Genre | : Medical |
| ISBN | : 0309065313 |
Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€"as well as the people who care for themâ€"with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€"in short, anyone who wants to learn more about this important issue.
